Biohazard: Every company has its strengths. For $DNDN it was commercial, for $ACAD it's manufacturing, for $VTL it's performing clinical trials.
3 days and 10 hours ago
Maxim Jacobs, CFA: $MNKD is making $DNDN look like a success story in comparison. At least people actually use Provenge.
4 days and 13 hours ago